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The goal of this study was to determine whether by-
pass replication occurs by translesion synthesis or tem-
plate switching (copy choice) when a duplex molecule
carrying a single cis,syn-cyclobutane thymine dimer is
replicated in vitro by human cell extracts. Circular het-
eroduplex DNA molecules were constructed to contain
the SV40 origin of replication and a mismatch opposite
to or nearby the dimer. Control molecules with only the
mismatch were also prepared. Heteroduplexes were
methylated at CpG islands and replicated in vitro (30
min). Following bisulfite treatment, the nascent DNA
complementary to the dimer-containing template was
distinguished from the other three strands by methyla-
tion-specific polymerase chain reaction. Cloning and se-
quencing of polymerase chain reaction products re-
vealed that 80–98% carried the sequence predicted for
translesion synthesis, with two adenines incorporated
opposite the dimer. The fraction of clones with sequence
predictive of template switching was reduced when ex-
tracts deficient in mismatch repair or nucleotide exci-
sion repair activities were used to replicate the hetero-
duplex molecules. These results support the conclusion
that lesion bypass during in vitro replication of duplex
DNA containing thymine dimers occurs by translesion
synthesis.
Genomes are constantly damaged through thermal, chemi-
cal, and radiation-induced reactions that cause modifications
in DNA structure. These can lead to mutations during replica-
tion of the damaged DNA. A network of DNA repair pathways
and checkpoint responses minimize this risk. Both prokaryotes
and eukaryotes are also endowed with DNA damage tolerance
pathways that increase survival by facilitating the duplication
of the genome, even in the presence of unrepaired lesions.
These pathways include lesion bypass during semi-conserva-
tive DNA synthesis by mechanisms that are not yet completely
understood (1, 2).
In the past 3 years, novel DNA polymerases have been iden-
tified and characterized in bacteria, yeast, and humans. These
new enzymes have in common the property of extending prim-
ers beyond a template DNA lesion during replication in vitro.
In Escherichia coli, they include the product of the dinB gene,
namely DNA polymerase (pol)1 IV (3), and UmuD92C (pol V) (4).
Saccharomyces cerevisiae contains two or three specialized
DNA polymerases encoded by the REV3, REV7, REV1, and
RAD30 genes. Rev3p and Rev7p are subunits of pol z (5). This
DNA polymerase together with Rev1p, a primer-template-de-
pendent deoxycytidyltransferase (6), appear to be responsible
for most of the mutagenic events in S. cerevisiae (7). By con-
trast, the product of the RAD30 gene (pol h) was shown to
bypass cyclobutane thymine dimers efficiently by inserting ad-
enines opposite this photoproduct (8).
The recent cloning of the human homologs of these new DNA
polymerases has drawn the suggestion that the process of
bypass replication of DNA lesions share common mechanisms
in prokaryotes and eukaryotes (9, 10). Accordingly, Gibbs and
collaborators (11, 12) have shown that the expression of hREV3
or hREV1 antisense RNAs in human fibroblasts reduces UV-
induced mutagenesis. Loss of pol h (hRad30A) leads to the
xeroderma pigmentosum variant (XP-V) syndrome (13–15).
XP-V patients are prone to skin cancer in areas exposed to the
sun (16), and their fibroblasts in culture are hypermutable by
UV light (17–21). This indicates that pol h in vivo protects
human cells from UV-induced mutagenesis by supporting the
bypass of UV-induced lesions in much the same way as Rad30p
does in yeast (8, 22). Also cloned recently were the human
homolog of E. coli dinB (23), encoding pol u (24), and another
homolog of S. cerevisiae RAD30, termed hRAD30B (25). The
latter is distinct from pol h (hRAD30A) but appears to encode
also a bypass DNA polymerase, pol i (26). Whether these novel
DNA polymerases contribute to the bypass of different DNA
lesions is still under investigation.
The preferred model of lesion bypass during DNA replication
calls for a step of translesion synthesis catalyzed by one of the
novel DNA polymerases described above (9, 10). One charac-
teristic of these new enzymes is that they synthesize DNA with
low processivity (27) and low fidelity (27, 29). This suggests
that the bypass polymerases might replace the replicative po-
lymerase blocked at the damage site, catalyze the addition of a
few nucleotides across the lesion (their active sites are thought
to be more tolerant of DNA distortions), and then dissociate
from the primer-template (27, 28). At this point, the main
replicase would return to the DNA growing point for efficient
(processive and faithful) duplication of the undamaged DNA (9,
10, 27, 28). An alternative model of lesion bypass calls for the
melting from the damaged template of the 39 end of the blocked
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strand and re-annealing to the complementary nascent DNA
strand (copy choice). This template-switching model was first
proposed by Higgins et al. (30) and Fujiwara and Tatsumi (31)
to explain bypass replication of UV-induced lesions in irradi-
ated human cells. Such a damage-avoidance mechanism has
been proposed to operate in bacteria (32) and yeast (33). There
is strong evidence that bypass polymerases, such as pol z (5)
and pol h (8, 13, 14, 28, 34), carry out translesion synthesis in
primer-extension assays in vitro. However, the possibility that
template switching might occur during the replication of a
duplex DNA, when the synthesis of both leading and lagging
strands takes place, has not been formally excluded.
The template-switching model did not receive much atten-
tion until recent years because it was assumed that interrup-
tion of leading strand synthesis by a template lesion would
result in complete blockage of the replication fork (35, 36).
Studies using in vitro replication of duplex DNA, however, has
provided evidence that uncoupling of leading and lagging
strand synthesis occurs when leading strand synthesis is
blocked by a template lesion (37–40). Under these conditions,
the replication fork continues to move beyond the damaged
site, extending the lagging strand by 1 to 2 thousand nucleo-
tides beyond the lesion (40, 41). These findings, as well as
evidence that extended single-stranded DNA regions are also
formed during DNA replication in UV-irradiated mammalian
cells (42, 43), suggested that a template-switching mechanism
was indeed quite plausible. The appeal of such a lesion bypass
pathway was its potential for high fidelity and for being inde-
pendent of the nature of the blocking lesion.
In this study we designed and carried out experiments to
determine whether translesion synthesis or template-strand
switching is the primary mechanism by which a site-specific
thymine dimer is bypassed during in vitro replication of a
duplex DNA. Heteroduplex circular molecules with or without
a single cis,syn-thymine dimer [T∧T] on the template to the
leading strand and a mismatch on the complementary template
were fully methylated at CpG islands and replicated in vitro by
several bypass-proficient human cell extracts. Leading strand
was successfully distinguished from the lagging strand and
methylated template strands by methylation-specific PCR, af-
ter the DNA was treated with bisulfite. Sequencing of cloned
PCR products revealed that translesion synthesis, and not
template switching, was the major mechanism by which cis,
syn-thymine dimers were bypassed during in vitro replication.
EXPERIMENTAL PROCEDURES
Cell Lines, Culture Conditions, and Preparation of Cell-free Ex-
tracts—HeLa S3 cells were obtained from the Lineberger Comprehen-
sive Cancer Center Tissue Culture Facility (University of North Caro-
lina, Chapel Hill) or from the National Cell Culture Center
(Minneapolis, MN). The IDH4 cell line was a gift from Dr. Jerry Shay
(University of Texas Southwestern Medical Center). This cell line was
generated by transformation with SV40 large T antigen of fibroblasts
from an apparently normal human fetus (44). SV40-transformed XPA
cells (XP12BE) were obtained from the NIGMS Human Genetic Mutant
Cell Repository (GM4429). The human colorectal cancer cell line
HCT116 (hMLH1 mutant, MMR defective; see Refs. 45 and 46) was
obtained from Dr. Thomas A. Kunkel from the NIEHS, National Insti-
tutes of Health. Cells were grown in monolayer cultures at 37 °C in an
atmosphere of 5% CO2 in air. HCT116 cells were maintained in a 1:1
mixture of Dulbecco’s modified Eagle’s medium and Ham’s F-12 me-
dium (Life Technologies, Inc.) with 10% fetal bovine serum (HyClone
Laboratories). The other cell lines were grown in Eagle’s minimal es-
sential medium, supplemented with 2 mM L-glutamine and 10% fetal
bovine serum. Growth medium for IDH4 cells also contained 1 mM
dexamethasone (Sigma). Replication-competent cell extracts for DNA
replication in vitro were prepared as published (47, 48).
Construction of Circular Heteroduplexes Molecules Containing a Mis-
match and a Single T∧T—The base changes required for the formation
of the mismatch in the final heteroduplex (Fig. 1) were introduced in the
sequence of the 1 strand of M13LeaSV (40). Mutated 1 strands for the
construction of Lea-C and T∧T-C were prepared essentially as described
(40), except that the 20-mer inserted into M13mp2SV (49) by site-direc-
ted mutagenesis (50) was changed by a single base (59-GAGCTCACT-
TAGTCAGCTGC-39). The mutated 1 strand in Lea-munI and T∧T-
munI were produced with the QuickChangeTM site-directed mutag-
enesis kit (Stratagene). The 35-bp oligonucleotides 59-CCGGCTCGAG-
CTCAATTGGTCAGCTGCGTATGTTG-39 and 59-CAACATACGCAGC-
TGACCAATTGAGCTCGAGCCGG-39 containing a point mutation at
position 389 (bold and underlined) were used to introduce a unique
MunI site into M13LeaSV. Mutated products were verified by sequenc-
ing of the 1 strands. Mutated closed circular single-stranded DNA was
purified and annealed with the oligonucleotide 39-CTCGAGT∧TAATC-
AGTCGACG-59 previously phosphorylated at the 59 end using T4
polynucleotide kinase (40). Then, second-strand synthesis, ligation, and
purification in CsCl gradients were carried out according to published
procedure (51). Control heteroduplex molecules (Lea-munI and Lea-C)
were prepared in the same manner, using an oligonucleotide of identical
sequence, but without the thymine dimer.
In Vitro DNA Replication—Heteroduplex DNA molecules were incu-
bated with the bacterial SssI methylase (New England Biolabs) for 2–3
h at 37 °C, under conditions suggested by the enzyme supplier for
methylation of CpG sites. Complete methylation was confirmed by
resistance of the closed circular heteroduplex molecules to digestion by
AciI (New England Biolabs), a restriction enzyme that cuts only un-
methylated DNA.
In vitro replication of the methylated heteroduplexes was carried out
in 25-ml reactions, as described previously (40), except that the concen-
tration of dCTP was reduced to 50 mM. Reaction mixtures lacking SV40
large T antigen were used as negative controls of in vitro DNA replica-
tion. After incubation at 37 °C for 30 min, reactions were terminated by
adding an equal volume of stop solution containing 2% SDS, 2 mg/ml
proteinase K, and 50 mM EDTA. DNA was purified by using the QIAEX
II Gel Extraction System (Qiagen). In experiments with T∧T-munI and
Lea-munI, the purified replication products were digested with MunI
(Roche Molecular Biochemicals) for 2–3 h at 37 °C. Aliquots of purified
DNA samples (;10 ng) were fractionated in 1% agarose gels containing
0.2 mg/ml ethidium bromide. Dried gels were exposed to a phosphor
screen that was later scanned by a PhosphorImagerTM (Molecular Dy-
namics, Sunnyvale, CA).
Bisulfite Treatment—Several protocols for bisulfite conversion of cy-
tosine to uracil in single-stranded DNA have been described (52–56). In
order to achieve efficient bisulfite conversion, the purified DNA was
first digested with XmnI restriction endonuclease (New England Bio-
labs) for 2–3 h at 37 °C. There are two XmnI recognition sequences in
the heteroduplex DNA used in these experiments (Fig. 1). The re-
stricted DNA (18 ml, ;30 ng) was denatured by incubation in 0.3 M
NaOH (addition of 2 ml of freshly prepared 3 M NaOH) for 15 min at
37 °C. Then, 200 ml of freshly prepared 5 M bisulfite solution, pH 5.0 (a
mixture of 2.5 M metabisulfite and 500 mM hydroquinone; Sigma), was
added to each reaction tube, followed by an incubation of 4 h at 50 °C.
The bisulfite-treated DNA was desalted by using the Wizard® DNA
clean-up system (Promega) and desulfonated by addition of 3 M NaOH
to a final concentration of 0.3 M. After 15 min at 37 °C, the solution was
neutralized by addition of 7.5 M NH4Oac, pH 7.0, to a final concentra-
tion of 3 M. DNA was precipitated with ethanol and resuspended in 12
ml of 10 mM Tris, containing 1 mM EDTA, pH 8.0, and used immediately
or stored at 220 °C.
PCR Amplification of the Bisulfite-treated DNA—The list of primers
used in this study is shown in Table I. Primers were designed for both
59339 and 39359 strands. Strand-specific primers for the selective
amplification of the replicated DNA (UNMET) or the methylated tem-
plate (MET), nonselective primers, and the sequencing primer were
designed using the GCG sequence analysis software package of the
Wisconsin Genetics Computer Group (version 7). Primers were synthe-
sized at the Pathology Oligonucleotide Synthesis Facility (University of
North Carolina, Chapel Hill).
PCR was carried out in a TouchdownTM Thermal Cycler with a
hot-start step that improved specificity. Reaction mixtures (50 ml) con-
taining 3 ml of bisulfite-treated DNA, 10 pmol of each PCR primer, 10
nM of each dNTP, and buffer supplied by Qiagen were placed in the
thermal cycler and hot-started at 94 °C for 4 min. After addition of 2.5
units of Taq polymerase (Qiagen) the denaturation step was continued
for 2 min, followed by the touchdown protocol (denaturation at 94 °C for
30 s, annealing at X °C for 30 s, extension at 72 °C for 30 s). The initial
annealing temperature of 61 °C was decreased at the rate of 1 °C for
every PCR cycle until the targeted temperature was reached (optimal
annealing temperature for the primers used; see Table I). At the target
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temperature, 19–20 regular PCR cycles were performed, followed by a
final extension step of 10 min at 72 °C. Negative controls for the strand-
specific primers were performed with each PCR set. Aliquots (2 ml) of
the PCRs were mixed with Ficoll loading buffer (3% Ficoll 400, 25 mM
EDTA, 0.025% Orange G) and subjected to electrophoresis in 1.2%
agarose gel containing 0.2 mg/ml ethidium bromide.
For direct sequencing, PCR products were purified using QIAquickTM
PCR product purification system (Qiagen). PCR products obtained from
59339 and 39359 strands of template, and replicated DNA was directly
sequenced using one of the PCR primers. PCR products obtained from
the leading strand of replicated DNA were subcloned using TA Cloning
Kit (Invitrogen). Plasmid DNA from individual clones were isolated
using WIZARD PLUS Minipreps Kit (Promega), checked for the pres-
ence of an insertion, and sequenced using the sequencing primer (Table
I). DNA sequencing was done at the University of North Carolina,
Chapel Hill, Automated DNA Sequencing Facility on a model 377 DNA
Sequencer (Perkin-Elmer) using the ABI PRISMTM Dye Terminator
Cycle Sequencing Ready Reaction Kit with AmpliTaq DNA polymerase.
The sequence data were analyzed using the GCG sequence analysis
software package of the Wisconsin Genetics Computer Group (version
7).
RESULTS
Substrate Design—Two sets of circular heteroduplex DNA
molecules were prepared for in vitro DNA replication (T∧T-
munI and T∧T-C), each containing a control molecule lacking
the T∧T dimer (Lea-munI and Lea-C, respectively). In the T∧T-
munI and T∧T-C substrates, the dimer was placed in the tem-
plate to the leading strand (for the first replication fork encoun-
tering the lesion), 385 bp from the center of the SV40 origin of
replication (Fig. 1). The two constructs differed only in the
location of the mismatched bases. In T∧T-munI, a T:G mis-
match was at position 389, 3 bp away from the T∧T dimer
(39-T∧TAAT-59:59-AATTG-39). This mismatch created a unique
MunI site in the replication product of the undamaged strand,
but the replication product of the damaged strand remained
resistant to MunI. The second heteroduplex (T∧T-C) contained
a T:C mismatch opposite the T∧T dimer (39-T∧TAA-59:59-ACTT-
39) at position 386. The single mismatch opposite (T∧T-C) or
nearby (T∧T-munI) the T∧T dimer was used as the marker of
the undamaged strand to discriminate whether DNA replica-
tion past the dimer occurred by translesion synthesis or tem-
plate switching. The diagram in Fig. 2 illustrates how these
two mechanisms could be distinguished by sequencing the
59339 leading strand of nascent DNA synthesized from T∧T-
munI. If translesion synthesis were the major mechanism by
which the replication machinery bypassed the lesion, the ex-
pected sequence of the leading strand (complementary to the
T∧T-containing template) would be AATTA (AATT with the
T∧T-C construct). In case of template strand switching (repli-
cation across the lesion was avoided by using the undamaged
lagging strand as template), the leading strand molecules
would carry the information from the marked undamaged
strand and display the sequence AATTG (ACTT with the T∧T-C
construct).
In Vitro Replication and Modification of DNA Strands—We
chose to carry out the in vitro replication reactions for 30 min
to maximize lesion bypass but to minimize the probability of a
second round of replication (38, 40, 41, 57). Circular heterodu-
plexes were first treated in vitro with SssI, an enzyme that
methylates cytosines exclusively at CpG dinucleotides in dou-
ble-stranded DNA (58). Resistance to digestion by AciI con-
firmed that the heteroduplex DNA was efficiently methylated
on both strands (there are 47 AciI recognition sites, 59-CCGC-
39, in the 7.4-kilobase pair circular molecule). Next, we deter-
mined that the methylated heteroduplexes could be replicated
in vitro by human cell-free extracts. SV40 large T antigen-de-
pendent replication of the fully methylated heteroduplexes rep-
resented 25–75% (varying with the extract and substrate used)
of that obtained in parallel reactions containing unmethylated
DNA (results not shown).
FIG. 1. Schematic representation of the two constructs used as
substrates for in vitro DNA replication. M13leaSV, a 7.4-kilobase
pair circular duplex molecule carrying the SV40 origin of replication
(40), was modified to contain a single T∧T in the 2 strand and a
mismatched base on the 1 strand. The location of the T∧T relative to the
SV40 origin of replication placed the dimer on the template to the
leading strand for the first replication fork to encounter the lesion. In
T∧T-C, a mismatched C was placed opposite the 59-T of the dimer. In
T∧T-munI, a G:T mismatch was placed 3 bp downstream from the dimer
to create a MunI recognition site upon replication of the undamaged
strand.
FIG. 2. Predicted intermediates of bypass replication of a T∧T
blocking leading strand synthesis. Uncoupling of lagging strand
synthesis, displacement of the replication fork beyond the dimer, and
formation of an extended single-stranded DNA region have been previ-
ously documented (41). This study sought to determine whether such
structures could represent intermediates of bypass replication by tem-
plate switching via the hypothetical configurations shown inside the
boxed inset. The mismatched base on the DNA strand complementary to
that carrying the T∧T provided the sequence marker needed to deter-
mine whether extension of the leading strand beyond the dimer (bypass
replication) occurred primarily by translesion synthesis or template
switching. DNA sequences surrounding the dimer in the T∧T-munI
construct are shown in bold (template DNA) and in italics (daughter
DNA) to illustrate the predicted sequence of the 59339 leading strand
following bypass replication according to one or the other of the two
potential models. The completion of a MunI recognition site upon rep-
lication of the 59339 template strand containing the mismatched G
should allow for the digestion of the resulting duplex prior to amplifi-
cation and sequencing of the nascent leading strand.
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Genomic sequencing after bisulfite modification was devel-
oped by Frommer and collaborators (52, 53). The method is
based on sodium bisulfite-mediated conversion of unmethyl-
ated cytosine to uracil under conditions whereby 5-methylcy-
tosines are resistant to this conversion. We used this approach
to distinguish the products of DNA replication in vitro (39359
and 59339 newly synthesized strands) from each other and
from their template strands. Single round of replication of
double-stranded templates fully methylated at CpG islands
yields two product molecules each containing one methylated
parental strand and one unmethylated newly synthesized
strand (Fig. 3A). Bisulfite reaction converts all unmethylated
cytosines to uracils, whether they are in the newly synthesized
or the template strands. There are two advantages of methyl-
ation and bisulfite modification of in vitro replicated DNA.
After treatment, the duplex DNA strands are no longer com-
plementary (Fig. 3B), and methylated template and unmethy-
lated nascent DNA strands of identical sequence and polarity
become divergent at CpG islands (Fig. 3C). Thus, bisulfite-
treated products of replication of duplex DNA methylated at
CpG islands become a mixture of four different strands that
can be selectively amplified by PCR with strand-specific
primers.
Primer Design—PCR primers were designed as described by
Herman et al. (59). They are listed in Table I, and their relative
hybridization positions on the target DNA strands are shown in
Fig. 3D. These primers were able to amplify efficiently both the
bisulfite-treated methylated and unmethylated strands of
M13leaSV (the parent plasmid used to generate heterodu-
plexes). A nonselective primer pair was also designed to check
the methylation status of the heteroduplex template strands
after the incubation with human cell extracts. This was neces-
sary to rule out possible contamination of leading strand DNA
with template strands demethylated during the in vitro repli-
cation reaction. In control experiments, methylated T∧T-munI
DNA was incubated for 30 min with either HeLa or IDH4
extracts in the absence of SV40 large T antigen (no semi-
conservative DNA replication). After bisulfite treatment, the
59339 strands were PCR-amplified using nonselective primers,
and the PCR products were purified and sequenced directly.
Results (not shown) revealed that methylated molecules re-
tained the CpG islands after incubation with human cell ex-
tracts. Sequencing histograms showed that each C peak at CpG
islands contained only one signal. No evidence was found for a
secondary (shadow) peak representing demethylated cytosines
(i.e. uracils) at positions corresponding to CpG islands. These
results clearly indicated that under conditions used for in vitro
replication the template DNA molecules remained methylated
and should not interfere with results obtained during the se-
quencing of the unmethylated newly synthesized DNA.
Reconstruction experiments were used to estimate the spec-
ificity of primers to amplify only the targeted strand among the
four expected to be present in the in vitro replication mixture
(Fig. 4). Use of touchdown PCR with a hot start improved the
specificity of primers, and no PCR products were detected in
the reactions containing negative controls. Unmethylated
M13leaSV was premixed with 103 the mass of methylated
M13leaSV. This mixture was treated with bisulfite, and ali-
quots were subjected to PCR using the 59–39-UNMET primer
set (Fig. 4A). Separate PCRs containing either bisulfite-treated
unmethylated DNA or 103 the mass of bisulfite-treated meth-
ylated DNA were used as controls. Note that only the bisulfite-
treated, unmethylated DNA was amplified with the 59–39-UN-
MET primer set. Fig. 4B illustrates the selective amplification
of the bisulfite-treated methylated DNA with the 59–39-MET
primer set. In this case, the methylated DNA that was treated
with bisulfite was mixed with 103 the mass of the untreated
methylated DNA. Only the bisulfite-treated DNA was ampli-
fied with the 59–39-MET primer set.
Next, we examined the specificity of the 59–39-UNMET prim-
ers to amplify bisulfite-treated DNA from an in vitro replica-
tion mixture containing the IDH4 extract and methylated
Lea-C as the substrate (Fig. 4C). DNA from in vitro replication
reactions in which methylated Lea-C was incubated with the
same extract in the absence of SV40 large T antigen (no repli-
cation) was used as an additional negative control. Efficient
PCR amplification with the 59–39-UNMET primers was only
observed with DNA from in vitro replication reactions when the
addition of SV40 large T antigen promoted the replication of
the methylated Lea-C substrate. Direct sequencing of PCR
products obtained with 59–39-UNMET and 39–59-UNMET
primer pairs revealed that all CpG dinucleotides were con-
verted into UpGs during bisulfite treatment and then PCR-
amplified as TpGs. Direct sequencing also revealed that the
59339 leading strand synthesized from the region of interest
(carrying the mismatch 39-TTAA-59:59-ACTT-39) was 59-AATT-
39, whereas the 39359 lagging strand was 39-TGAA-59 (under-
lining added for emphasis). Both template strands were ampli-
fied from the same in vitro replication reaction using 59–39-
FIG. 3. Basis for selective PCR amplification of each of four
DNA strands of a replicated duplex molecule. A, SssI methylation
of template DNA at CpG islands (C) does not interfere with semicon-
servative DNA replication. B, bisulfite treatment leads to deamination
of unmethylated cytosines to uracil (same base pairing characteristics
as thymine). This results in loss of base pairing between the two
initially complementary strands. C, sequence divergence at CpG is-
lands between template and nascent DNA of identical polarity allows
for the design of PCR primers that amplify specifically one strand over
the other. Methylated cytosines in template DNA (bold) are underlined,
and the nascent DNA is shown in italics. D, diagram indicating the
relative positions and directions of primers used during methylation-
specific PCR to amplify individual strands of DNA replicated in vitro.
Thick lines represent methylated template strands (MET); the filled
triangle on the 39359 template strand represents the site-specific thy-
mine dimer. Thin lines stand for the DNA newly synthesized in vitro,
thereby unmethylated (UNMET). Forward (F) and reverse (R) primers
are numbered according to their presentation in Table I. Dotted lines
represent DNA synthesized during PCR.
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MET and 39–59-MET primer sets and sequenced directly.
Results showed that all CpG dinucleotides were protected by
methylation in both template strands during bisulfite reaction.
The 59-ACTT-39 template strand (mismatch-containing region)
was amplified during PCR as 59-ATTT-39 (unmethylated cyto-
sine was converted to U and then to T) and 39-TTAA-59 tem-
plate strand was amplified as 39-TTAA-59.
Sequence Analysis of in Vitro Replication Products of Un-
damaged Heteroduplexes—Methylated Lea-munI (39-TTAAT-
59:59-AATTG-39) was replicated in vitro by HeLa and IDH4
extracts and treated with bisulfite after XmnI and MunI diges-
tion. As emphasized above, the mismatch in this construction
leads to the introduction of a recognition site for MunI in the
replication product of the 59339 template strand. After com-
plete digestion with MunI, neither the 39359 lagging nascent
strand nor the 59339 template strand in replicated molecules
should be available for PCR amplification. After bisulfite treat-
ment, the 59339 leading nascent strand from three independ-
ent in vitro replication reactions with methylated Lea-munI
was amplified with the 59–39-UNMET primers and directly
sequenced. This analysis confirmed that the targeted repli-
cated strands were amplified because ;90–100% of the CpG
dinucleotides in the amplified DNA was converted to TpGs. For
sequencing analysis of individual molecules, PCR products
were obtained from four independent in vitro replication reac-
tions conducted with one of two human cell extracts (IDH4 and
HeLa) and cloned. Approximately 20–25 cloned molecules from
each reaction were sequenced, and the results are shown in
Table II. The data revealed that 91 (HeLa, n 5 45) and 98%
(IDH4, n 5 46) of sequenced molecules displayed the expected
sequence AATTA. Similar results were obtained when the sec-
ond heteroduplex, Lea-C (39-TTAA-59:59-ACTT-39), was repli-
cated by the IDH4 extract. Among the 18 sequenced clones, 17
(94%) displayed the expected sequence AATT and only one (6%)
showed the ACTT sequence (Table IV). We were surprised to
find leading strand clones carrying the sequence ACTT (Lea-C;
6% in IDH4, Table IV) or the sequence AATTG (Lea-munI; 9%
in HeLa and 2% in IDH4, Table II) among products of replica-
tion of the undamaged constructs. Therefore, we consider
whether these clones could reflect the activity of mismatch
repair (MMR) on the heteroduplex prior to DNA replication
(60). The experiments were repeated with an extract of
HCT116, an MMR-deficient cell line, and the results showed
that all 49 sequenced clones (two independent in vitro replica-
tion reactions) carried the sequence AATTA (Table II).
Sequence Analysis of in Vitro Replication Products of T∧T
Dimer-containing Heteroduplexes—T∧TmunI heteroduplex
molecules were incubated in vitro with bypass-proficient ex-
tracts from HeLa and IDH4. Newly synthesized leading strand
molecules were analyzed as described for the corresponding
undamaged heteroduplex molecules. PCR products obtained
from three independent in vitro replications were sequenced
directly. Sequence histograms showed that the peak corre-
sponding to the 39- A at the 59-AATTA-39 region contained one
strong A signal and a smaller G peak, indicating that the
population of amplified molecules was heterogeneous in this
region. After cloning of PCR products and sequencing of indi-
vidual molecules, the data summarized in Table III were ob-
tained. Among the molecules synthesized by HeLa (n 5 40) and
IDH4 (n 5 46), 80 and 87% displayed the sequence AATTA,
which was consistent with bypass replication taking place by
translesion synthesis (Fig. 2). Clones carrying the sequence
AATTG constituted 20% in HeLa and 13% in IDH4. According
to our experimental design, the detection of AATTG sequences
among the bypass products would indicate that direct damage
bypass could be avoided by a template-switching mechanism.
Before reaching the conclusion that such pathway was func-
tioning during the replication of a small fraction of heterodu-
plex molecules, it was important to determine whether DNA
repair activities could be distorting the experimental results.
Both IDH4 and HeLa extracts are proficient in nucleotide
excision repair (NER) and MMR. The heteroduplexes used in
this study carry a compound lesion (a mismatch opposite the
FIG. 4. Specificity of PCR primers (see Table I). A, selective
amplification of bisulfite-treated, unmethylated DNA by the 59-39-UN-
MET primer set. Lane 1, mixture of 4 ng of bisulfite-treated, unmethy-
lated M13leaSV DNA with 40 ng of bisulfite-treated methylated
M13leaSV; lane 2, 4 ng of bisulfite-treated, unmethylated M13leaSV
DNA; lane 3, 40 ng of bisulfate-treated, methylated M13leaSV; lane 4,
PCR reaction with no DNA. B, selective amplification of bisulfite-
treated, methylated DNA by the 59–39-MET primer set. Lane 1, mixture
of 4 ng of bisulfite-treated, and 40 ng of untreated, methylated
M13leaSV DNA; lane 2, 4 ng of bisulfite-treated, methylated M13leaSV
DNA; lane 3, 40 ng of methylated M13leaSV not treated with bisulfite;
lane 4, no DNA. C, selective amplification of unmethylated nascent
DNA with the 59–39-UNMET primer set after replication in vitro of
methylated Lea-C DNA. Lane 1, bisulfite-treated DNA from in vitro
replication reactions containing methylated Lea-C DNA but lacking
SV40 large T antigen; lanes 2 and 3, bisulfite-treated DNA after SV40
large T antigen-dependent in vitro replication of methylated Lea-C
DNA; lane 4, bisulfite-treated methylated Lea-C DNA not incubated in
vitro; lane 5, no DNA. M marks the lanes containing size markers
(100-bp DNA ladder, Life Technologies, Inc.).
TABLE I
Primer sets for methylation-specific PCR amplification of DNA strands from replicated duplex DNA (see Figs. 1 and 3D)
Underlined nucleotides represent positions protected from deamination by SssI methylation of template DNA but modified by bisulfite treatment
in replicated DNA; sequence differences between primers and DNA not treated with bisulfite are in boldface. See Fig. 3D for schematic
representation of the relative positions and directions of these primers.
Primers AmplifiedDNA strand Forward primers 59339 Reverse primers 59339
Product
length
Optimal
annealing
temperature
°C
1) 59–39-MET Template CGTAAATCGTTTTTTTTC ACACCGCTTCTAATACC 436 50.4
2) 39–59-MET Template ATGGGCGTATCGTAATC GAACTAAAAACGAACAATAAAC 461 51.7
3) 59–39-
UNMET
Leading TATGGGGTGGAGAATGGGT CACAACTATTAAAAAAAACAATCAATACA 570 52.0
4) 39–59-
UNMET
Lagging GTGTGGGTTTTTTTGTTATTATGT CTAACACCCAATACACAAACCA 375 51.5
5) 59–39 Non-
selective
Template 1
Leading
TAGGCGGTGAAGGGTAA AATACCGAAAACCAAACAA 495 51.6
6) Sequencing Leading CCAACTAACAAAAAAAAAATATACTACAAAACA
Bypass Replication of Thymine Dimers 30947
T∧T dimer), and such lesions are better substrates for NER
than the simple T∧T (61). If some molecules of T∧T-munI (39-
T∧TAAT-59:59-AATTG-39) were repaired by NER to 39-TTAAC-
59:59-AATTG-39, the replication of the repaired 39-TTAAC-59
strand would generate leading strand molecules with the se-
quence AATTG. If the repaired and replicated molecules es-
caped MunI digestion, then AATTG clones could be recovered
in our experiments without template switching having oc-
curred during bypass replication. We also considered that if
AATTG clones resulted from bypass replication by template
switching, but post-replication repair corrected the mismatch
by copying the template strand (39-T∧TAAT-59:59-AATTG-39
repaired to 39-T∧TAAT-59:59-AATTA-39), then our results could
be distorted in favor of translesion synthesis. If that was the
case, the percentage of AATTG clones should increase when
MMR-deficient extracts were used to replicate the heterodu-
plex molecules. Therefore, these experiments were repeated
with extracts from NER-deficient (XPA) and MMR-deficient
(HCT116) cells. The data in Table III show that 93% of the
leading strand molecules displayed the sequence AATTA and
only 7% AATTG when in vitro replication was supported by the
HCT116 extract. Therefore, a reduction and not an increase in
the number of AATTG clones was observed in the absence of
MMR activity. This observation strengthened the suspicion
that prereplicative NER (and not template switching) could be
the major source of the observed AATTG clones. This was
confirmed by the results with an extract from XPA cells (NER-
deficient). Among the 45 clones sequenced, only one (2%) dis-
played the sequence AATTG (Table III).
The results presented in Tables II and III strongly suggest
that bypass replication of a single cis,syn-thymine dimer in
duplex DNA occurs primarily by translesion synthesis. This
conclusion was confirmed by the results obtained with the
T∧T-C construct (39-T∧TAA-59:59-ACTT-39) and shown in Table
IV. After in vitro replication by IDH4 and HCT116 extracts, the
sequence of the leading strand was found to be AATT in 84%
(IDH4, n 5 56) and 82% (HCT116, n 5 39) of the clones.
DISCUSSION
The significance of the data reported here rests on the dem-
onstration that human replication complexes carry out bypass
replication of a pyrimidine dimer in duplex DNA by translesion
synthesis. Although this conclusion may seem obvious to many,
this is the first analytical study designed to test this assertion
experimentally. Recent discoveries of several novel DNA poly-
merases with bypass replication capability in primer extension
reactions reinforced the expectation that polymerization across
non-instructive lesions in duplex DNA is the norm. In addition,
the in vitro replication of single-stranded vectors containing a
single acetylaminofluorene adduct demonstrated that transle-
sion synthesis through and beyond the damaged site can be
catalyzed by extracts from bypass-proficient human cells (34).
However, other pieces of evidence kept pointing to an alterna-
tive mechanism, mainly template switching, as a plausible
pathway of damage tolerance when lesions are encountered
during the replication of duplex DNA.
The potential co-existence in the same replication fork of a
newly synthesized daughter DNA, with the same sequence and
polarity as the lesion-containing template, was thought to hold
the key to the mechanism by which DNA polymerization could
be guided beyond the blocking lesion (Fig. 2). When this model
was initially proposed (30, 31), however, it was met with skep-
ticism. One of the experimental evidence presented in support
of the model was the detection by electron microscopy of four-
armed replication forks (see boxed inset in Fig. 2). These struc-
tures, however, could have been formed in solution by DNA
branch migration instead of representing true intermediates of
bypass replication. In the absence of conclusive proof in favor of
or against template switching, this model remained appealing
because it envisioned an error-free alternative for the comple-
tion of DNA replication, despite the presence of DNA damage in
the genome. In vitro replication studies aimed at detecting
replication past site-specific DNA lesions demonstrated that
blockage of the leading strand at a damaged site did not inter-
rupt the progression of the replication fork (37–40). In a large
fraction of the replicating molecules, the attendant DNA syn-
thesis resulted in polymerization of the lagging strand beyond
the lesion, even before bypass could take place (41). These
observations made clear that the necessary prerequisite for
template switching, i.e. an undamaged 39359 nascent strand to
serve as the alternative template to the growing leading
TABLE II
Sequence of the 593 39 leading strand of nascent DNA from Lea-munI replicated in vitro by different extracts
Lea-munI
39-TTAAT-59
59-AATTG-39
Extract MMR capabilitya No. of sequenced clonesb
No. (%) of clones with sequence:
AATTA AATTG
HeLa Proficient 45 41 (91%) 4 (9%)
IDH4 Proficient 46 45 (98%) 1 (2%)
HCT116 Deficient 49 49 (100%) 0 (0%)
a MMR capability of these extract was confirmed by Dr. Alan Clark in Dr. Thomas A. Kunkel’s laboratory (NIEHS, National Institutes of Health).
b Clones recovered from two independent experiments.
TABLE III
Sequence of the 59339 leading strand of nascent DNA from T∧T-munI replicated in vitro by different extracts
T∧TmunI
39-T∧TAAT-59
59-A ATTG-39
Extract Repair capabilitya No. of sequenced clonesb
No. (%) of clones with sequence:
AATTA
(translesion synthesis)
AATTG
(template switching?)
HeLa MMR and NER-proficient 40 32 (80%) 8 (20%)
IDH4 MMR and NER-proficient 46 40 (87%) 6 (13%)
HCT116 MMR-deficient 46 43 (93%) 3 (7%)
XPA NER-deficient 45 44 (98%) 1 (2%)
a Indicates proficiency or deficiency in MMR and NER.
b Clones recovered from two independent experiments.
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strand, was indeed present at the damaged site. Therefore, it
became important to design experiments to detect whether
bypass replication by template switching was occurring in
vitro.
The first experimental challenge was to mark the template
strands, so that we could determine which one directed the
synthesis of the DNA later found opposite the T∧T. This was
the purpose of adding a mismatched base opposite to or nearby
the dimer in the two constructs used in this study (Figs. 1 and
2). Once bypass had taken place, we needed to determine
without ambiguity the sequence of the newly synthesized lead-
ing strand. By using technology developed to study DNA meth-
ylation patterns, it was possible to distinguish the four strands
of the duplex DNA and to amplify them selectively. The prin-
ciples of this approach are illustrated in Fig. 3. Methylation
protection of bisulfite deamination of cytosines, in stretches of
the template strands containing at least three CpG islands,
provided sufficient sequence divergence from the newly synthe-
sized DNA, which prior to chemical treatment had an identical
sequence and polarity. The positive and negative controls illus-
trated in Fig. 4, and subsequent sequencing analyses, demon-
strated that the strand-specific primers listed in Table I indeed
amplified only the targeted strand. These results set the stage
for the determination of the sequence of interest, that is the one
carried by the 59339 leading strand complementary to the
dimer-containing template. We cloned PCR products and se-
quenced individual molecules so that both major and minor
events could be detected.
The final results shown in Tables II–IV strongly support the
conclusion that translesion synthesis, most likely catalyzed by
pol h, was responsible for the insertion of adenines opposite the
T∧T in .80% of the bypass products, without transfer of se-
quence information from the alternative template. Further-
more, the fraction of bypass products with the sequence pre-
dictive of template switching was dependent on the capability
of the extract for DNA repair. The use of human cell extracts
that were deficient in NER or MMR resulted in reductions in
the number of clones carrying the sequence information of the
nascent lagging strand. This finding suggested that the
AATTG (ACTT) clones were not the product of template switch-
ing during bypass but instead were generated by DNA repair
occurring prior to DNA replication. Remaining to be explained
is why the repaired and replicated molecules carrying the se-
quence 39-TTAAC-59:59-AATTG-39 were amplified by methyla-
tion-specific PCR when they should have been digested by
MunI. Although we optimized the reaction conditions for com-
plete digestion of molecules carrying the MunI recognition se-
quence, it is possible that some products of in vitro replication
could have escaped digestion due to proteins remaining bound
to the replicated DNA, even after its purification with the
QIAEX II Gel Extraction System. The interpretation that tem-
plate switching can occur in a small fraction of the replicating
molecules, however, cannot be completely dismissed at this
point. It can be argued that replication-competent extracts
prepared from different human cell lines might differ in their
capability to support template switching relative to translesion
synthesis.
The maintenance of genetic stability requires that DNA rep-
lication be carried out with the highest degree of fidelity. This
is accomplished by the combined action of DNA polymerases
with low frequency of errors, proofreading activities, and post-
replication repair. These functions depend on the recognition of
correct base pairing between the template and the nascent
strands. However, when the replication machinery encounters
damaged sites in DNA, less stringent base pairing conditions
must be accommodated (28, 29), if DNA synthesis across and
beyond the lesion is to take place. This balance between high
fidelity during the replication of normal DNA and the need to
complete replication even in the presence of DNA lesions re-
quires the concerted effort of different DNA polymerases. Even
though the regulation of DNA polymerase switching at sites of
blocked DNA replication is not yet understood, the results
reported here demonstrate that translesion synthesis is the
major mechanism by which a cyclobutane thymine dimer is
bypassed during in vitro replication.
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